Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Gains from Investment Securities (2020 - 2025)

Pulse Biosciences has reported Gains from Investment Securities over the past 6 years, most recently at -$28000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$28000.0 for Q4 2025, down 103.37% from a year ago — trailing twelve months through Dec 2025 was $571000.0 (down 20.47% YoY), and the annual figure for FY2024 was $11.0 million, up 78.76%.
  • Gains from Investment Securities for Q4 2025 was -$28000.0 at Pulse Biosciences, down from $1.2 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PLSE hit a ceiling of $6.1 million in Q4 2023 and a floor of -$232000.0 in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was $398660.0 (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 294.96% in 2021 and later soared 20235.4% in 2022.
  • Pulse Biosciences' Gains from Investment Securities stood at -$232000.0 in 2021, then surged by 324.27% to $520302.0 in 2022, then surged by 1080.45% to $6.1 million in 2023, then tumbled by 86.49% to $830000.0 in 2024, then tumbled by 103.37% to -$28000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$28000.0 (Q4 2025), $1.2 million (Q3 2025), and $830000.0 (Q4 2024) per Business Quant data.